Writaja Halder
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
-
- Gastrointestinal Bleeding Diagnosis and Treatment 1
- Co-authors
- Rubina Aktar (1 shared paper)Vincent Cibert‐Goton (1 shared paper)Charles H. Knowles (1 shared paper)David E. Reed (1 shared paper)L. Ashley Blackshaw (1 shared paper)Madusha Peiris (1 shared paper)Owen Epstein (1 shared paper)Sergio Coda (1 shared paper)
- Journals
- The Lancet (5 papers)Gut (1 paper)The Lancet Diabetes & Endocrinology (1 paper)The Lancet Infectious Diseases (1 paper)EClinicalMedicine (1 paper)
- Partner nations
- United KingdomAustraliaVietnam
In The Last Decade
Writaja Halder
11 papers receiving 1.2k citations
Writaja Halder's Hit Papers
Peers
Comparison fields: 5 of 95
- Infectious Diseases 739
- Neurology 256
- Internal Medicine 54
- Obstetrics and Gynecology 71
- Critical Care and Intensive Care Medicine 35
Countries citing papers authored by Writaja Halder
This map shows the geographic impact of Writaja Halder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Writaja Halder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Writaja Halder more than expected).
Fields of papers citing papers by Writaja Halder
This network shows the impact of papers produced by Writaja Halder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Writaja Halder. The network helps show where Writaja Halder may publish in the future.
Co-authors
The 10 scholars most cited alongside Writaja Halder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 2 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 3 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 4 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 5 | 2023 | 83 | |
| 6 | 2021 | 30 | |
| 7 | 2023 | 24 | |
| 8 | 2024 | 23 | |
| 9 | 2022 | 7 | |
| 10 | 2025 | 5 | |
| 11 | 2025 | 2 |
About Writaja Halder
Writaja Halder is a scholar working on Infectious Diseases, Gastroenterology, Surgery, Oncology and Insect Science, having authored 11 papers that have together received 1.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Gastrointestinal Bleeding Diagnosis and Treatment (1 paper), Colorectal Cancer Screening and Detection (1 paper), Gastrointestinal disorders and treatments (1 paper) and Kawasaki Disease and Coronary Complications (1 paper). The work is most often cited by research in Infectious Diseases (739 citations), Neurology (256 citations), Internal Medicine (54 citations), Obstetrics and Gynecology (71 citations) and Critical Care and Intensive Care Medicine (35 citations). Writaja Halder has collaborated with scholars based in United Kingdom, Australia and Vietnam. Frequent co-authors include Rubina Aktar, Vincent Cibert‐Goton, Charles H. Knowles, David E. Reed, L. Ashley Blackshaw, Madusha Peiris, Owen Epstein, Sergio Coda, Faidon‐Marios Laskaratos and Saswata Banerjee. Their work appears in journals such as The Lancet, Gut, The Lancet Diabetes & Endocrinology, The Lancet Infectious Diseases and EClinicalMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.